Alcyone Lifesciences, DNAtrix form drug delivery alliance; Oral steroids found ineffective at speeding recovery following surgery;

> Alcyone Lifesciences and DNAtrix are in an alliance. DNAtrix will utilize Alcyone's MEMS Cannula targeted delivery platform for the intratumoral delivery of its lead brain cancer candidate. More

> A study in the Journal of the American Medical Association found that oral steroids are likely ineffective at speeding recovery from lumbar radiculopathy. More

Suggested Articles

J&J figures its partner Genmab owes a share of Darzalex Faspro royalties to Halozyme for its subcutaneous delivery tech. Genmab doesn't agree.

Bexson Biomedical and Stevanato Group teamed up to develop a ketamine pump that may help patients better manage pain at home.

Australia's University of New South Wales and Uka Tarsadia University in India will join forces to explore contact lenses for ocular drug delivery.